Approximately 80% of all sensory input is received via the eyes, so suffering from chronic retinal diseases that lead to blindness causes a significant decrease in the quality of life (QOL). And because retinal diseases are most common among the elderly, developing pathological analyses and treatments for retinal diseases has become an urgent issue in super-aging countries such as Japan.
Although evaluation of drug candidates against retinal diseases has been done on animal models, serious concerns arise regarding the ethics and costs in addition to the limitations of translating data from animal models to clinical settings.
In vitro cell culture models, an alternative to animal models, enable researchers to investigate specific molecules-of-interest and simply recapitulate complex and chronic conditions. Although studies on organ-on-a-chip for drug discovery have recently been extensively carried out, the organ-on-a-chip approach that targets the ocular tissues has been rarely investigated.
A joint research team from the Graduate Schools of Engineering and Medicine at Tohoku University has recapitulated a pathological condition of retinal diseases on a chip. They first cultured human retinal cells and vascular endothelial cells, mimicking the outermost structure of the retina.
When retinal cells were exposed to hypoglycemic and hypoxic conditions after the cells had grown up, endothelial cells were found to migrate to the side of retinal cells to damage them. This process partially recapitulates neovascularization in wet-type age-related macular degeneration (AMD).
Learn more: Reproducing a retinal disease on a chip
The Latest on: Retinal disease on a chip
[google_news title=”” keyword=”retinal disease on a chip” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- COVID-19 virus can breach blood-retinal barrier, study findson May 15, 2024 at 4:52 am
The blood-retinal barrier is designed to protect our vision from infections by preventing microbial pathogens from reaching the retina where they could trigger an inflammatory response with potential ...
- OTLK Outlook Therapeutics, Inc.on May 14, 2024 at 9:07 pm
Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead ...
- 5 Medical Info Systems Stocks to Buy for Stable Returnson May 10, 2024 at 5:29 am
The medical info systems industry is thriving due to the growing demand for contactless services. The industry witnessed exponential growth during the pandemic era. Even in the post-pandemic period, ...
- Apple M4 Chip With On-Device AI, Ray Tracing and Ultra Retina XDR Display Support Launchedon May 8, 2024 at 12:53 am
Apple says the M4 chip was designed for its new display engine that enables the 'Tandem OLED' technology on the iPad Pro (2024).
- The best MacBook to buy in 2024on May 7, 2024 at 5:00 pm
With M3 chips outfitted across the entire MacBook range, you might be wondering which is the best MacBook to buy in 2024. Figuring it out isn't always easy, and buying the newest MacBook might not ...
- Apple debuts new iPad Pro with M4 chip, iPad Air tabletson May 7, 2024 at 3:42 pm
Apple held its "Let Loose" iPad event Tuesday, unveiling the new iPad Pro, iPad Air and Apple Pencil Pro in what chief executive officer Tim Cook called "the biggest day for iPad since its ...
- The best iPads in 2024: the 5 best ones you should buyon April 22, 2024 at 4:59 pm
Apple's iPad is undoubtedly one of the most popular tablets on the market right now. There are several different models to choose from, but no matter which one you go with, you'll be getting one ...
- Report: How Top 12 Medical Companies Provide Cost-Effective AI Healthcare Serviceson February 29, 2024 at 6:44 am
Artificial Intelligence (AI) revolutionizes medical diagnosis, treatment, and patient care. AI was once a work of fiction, but today, it permeates our everyday lives thanks to tec ...
- 24-inch iMac with Retina 4.5K display: Apple M1 chipon August 4, 2022 at 10:15 pm
Designed for Mac, M1 delivers faster CPU performance and faster graphics. M1 optimizes custom technologies and power efficiency for the new iMac. The system-on-a-chip design provides greater ...
- AAO: Inherited Retinal Diseaseon November 14, 2021 at 4:00 pm
Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...
via Google News and Bing News